The Comprehensive Guide To Interdisciplinary Veterinary Social Work

Designed for veterinarians, veterinary students, and vet techs, this essential guide bridges clinical medicine and emotional wellness to transform how you navigate difficult client conversations, ethical dilemmas, and team dynamics. Gain practical, evidence-based strategies for managing compassion fatigue, supporting grieving pet owners, and building resilient workplace cultures that protect both staff and patients. Through real-world case studies and actionable frameworks, discover how interdisciplinary social work strengthens the human-animal bond while safeguarding your own wellbeing. Instant digital download — start reading immediately.

Table of Contents

• Contents (p.6)
• 1 Animal Welfare – Definition(s) (p.11)
• 2 Why and How Should We Assess Animal Welfare? (p.13)
• 3 On-Farm Animal Welfare Assessment (p.13)
• 4 Which Indicators Should We Use? (p.14)
• 5 Building a Welfare Assessment Protocol Step by Step (p.15)
• 6 CIISA’s Work with Farm Animal Welfare Assessment Protocols (p.18)
• 7 Final Comments (p.30)
• References (p.30)
• 1 Causing Pain in Farm Animals and Its Impact on Animal Welfare (p.35)
• 2 What Kind of Pain Are We Talking About? (p.37)
• 3 How to Recognize Pain During and After Routine Procedures? (p.39)
• 4 How to Manage Pain in Farm Animals – Constraints and Opportunities (p.41)
• 5 Research on the Most Important Sources of Pain in Farm Ruminants (p.43)
• 6 Conclusions (p.52)
• References (p.53)
• 1 The Origins of Creole Livestock (p.61)
• 2 Cattle (p.62)
• 3 Pigs (p.67)
• 4 Goats (p.70)
• 5 Horses (p.72)
• 6 Donkey (p.73)
• 7 Conclusions (p.74)
• 8 Future Perspectives (p.74)
• References (p.75)
• 1 Introduction (p.77)
• 2 Experimental Procedures (p.79)
• 3 Carcass Traits (p.79)
• 4 Meat Characteristics (p.83)
• 5 Sensory Attributes (p.85)
• 6 Genome-Wide Association Study (p.88)
• 7 Conclusions (p.90)
• References (p.91)
• 1 Introduction (p.95)
• 2 Hydrolysis of Structural Carbohydrates (p.96)
• 3 Mammalian Gut Fibrolytic Activity (p.97)
• 4 The Cellulosome (p.98)
• 5 The Cohesin-Dockerin Interaction (p.99)
• 6 Type I Coh-Doc Interactions and Cellulosome Assembly (p.101)
• 7 Type II Coh-Doc Interactions and Cellulosome Cell-Surface Attachment (p.105)
• 8 Ruminococcal Single-Binding Mode Type III Coh-Doc Interactions (p.106)
• 9 Cellulosome Diversity (p.108)
• 10 Biotechnological and Potential Applications for Cellulosomes (p.110)
• 11 Conclusions (p.110)
• References (p.111)
• 1 Introduction (p.117)
• 2 Carbohydrate-Active Enzymes (CAZymes) (p.117)
• 3 Carbohydrate-Binding Modules (CBMs) (p.119)
• 4 Anti-nutritive Properties of Non-starch Polysaccharides (NSPs) in Animal Nutrition (p.122)
• 5 Are Exogenous Enzymes Really Required for All Barley-Based Diets? (p.123)
• 6 Cellulases or β-Glucanases? What Are the Best Enzymes to Improve the Nutritive Value of Barley-Based Diets for Poultry? (p.125)
• 7 Role of CBMs in Exogenous Enzymes Used in Animal Nutrition (p.126)
• 8 Temporal Restriction of Exogenous Enzyme Supplementation (p.127)
• 9 Novel Insights into the Mechanism of Action of Feed Xylanases (p.129)
• 10 Conclusions (p.131)
• References (p.132)
• 1 Introduction (p.136)
• 2 Morphology and Phenology (p.140)
• 3 Chemical Composition and Nutritional Value (p.140)
• 4 Biological Activities (p.144)
• 5 Cistus ladanifer in Ruminant Diets (p.145)
• 6 Conclusions (p.162)
• References (p.162)
• 1 Introduction (p.170)
• 2 Pork Production and Quality (p.170)
• 3 Pork Production with Low Protein Diets (p.173)
• 4 Pork Production with Dietary Microalgae (p.177)
• 5 Conclusion and Future Perspectives (p.180)
• References (p.181)
• 1 Introduction (p.186)
• 2 The Lusitano Breed: A Brief Characterization (p.187)
• 3 Growth and Development of the Foal (p.191)
• 4 Final Remarks (p.200)
• References (p.201)
• 1 Introduction (p.207)
• 2 The In Situ and Ex Situ Preservation of Animal Genetic Resources (p.208)
• 3 Cryopreservation of Gametes and Embryos (p.209)
• References (p.217)
• 1 Introduction (p.224)
• 2 Work on Animal Seasonal Feed Restriction and Metabolism (p.225)
• 3 Work on Animal Health (p.231)
• 4 Work on Plant Adaptation to Hyperthermia and Draught Environments (p.232)
• 5 Work on Food Security and Rural Development (p.234)
• 6 Conclusion (p.236)
• References (p.236)
• 1 The Gut Microbiome (p.240)
• 2 Methods to Study the Gut Microbiome (p.241)
• 3 Gut Microbiome and Antimicrobial Resistance (p.243)
• References (p.247)
• 1 Urinary Tract Infections (p.253)
• 2 Pathophysiology and Predisposing Factors (p.254)
• 3 Classification of Urinary Tract Infections and Diagnosis (p.254)
• 4 Aetiology (p.255)
• 5 Antimicrobials for UTI Treatment in Companion Animals (p.256)
• 6 Antimicrobial Resistance Surveillance in Companion Animals (p.258)
• 7 Multidrug Resistance Bacteria Causing UTIs from Companion Animals (p.262)
• References (p.264)
• 1 The Antimicrobial Use in Veterinary Medicine (p.272)
• 2 Risk of Transfer of Antimicrobial-Resistant Bacteria (p.273)
• 3 Antimicrobial Resistance Mechanisms and Bacteria of Concern (p.274)
• 4 Enterobacteriaceae and Non-Enterobacteriaceae (p.277)
• 5 The Future (p.278)
• References (p.279)
• References (p.291)
• 1 Introduction (p.295)
• 2 Feline Immunodeficiency Virus (p.297)
• 3 Feline Coronavirus (p.299)
• 4 Virus Surveillance (p.300)
• 5 Virus and Marine Mammals (p.301)
• 6 Sea Turtles and Fibropapillomatosis (p.302)
• 7 Conclusion (p.303)
• References (p.303)
• References (p.322)
• References (p.344)
• 1 Introduction (p.352)
• 2 Material and Methods (p.352)
• 3 Quantitative Technique (p.353)
• 4 Qualitative Technique (p.354)
• 5 Faecal Cultures (p.355)
• 6 Scotch Tape Technique (p.358)
• 7 Macroscopic Examination (p.358)
• 8 Monitoring the Efficacy of Deworming Protocols (p.359)
• 9 Statistical Analysis (p.360)
• 10 Results and Discussion (p.361)
• 11 EPG Counts (p.362)
• 12 STOP Survey (p.363)
• 13 Intestinal Strongyles EPG Peaks (p.364)
• 14 Prevalence of Identified Parasites (p.365)
• 15 Faecal Cultures (p.368)
• 16 Parasite Control (p.368)
• 17 Conclusion (p.371)
• References (p.372)
• 1 Introduction (p.378)
• 2 Prions, the Great Villains (p.379)
• 3 The Bright Side of Prions (p.380)
• 4 Prions Are Forever (p.387)
• References (p.388)
• 1 Introduction (p.394)
• 2 The Notch Signaling Pathway (p.395)
• 3 Notch Enrolment in Mouse Post-natal Testis Development (p.395)
• 4 Notch Enrollment in Spermatogenesis (p.397)
• 5 Notch Enrolment in Ovarian Post-natal Development (p.399)
• 6 Notch Enrollment in Ovarian Follicular and Luteal Development (p.399)
• References (p.403)
• 1 The Notch Signalling Pathway (p.408)
• 2 Dll4 Signalling in Vascular Development (p.409)
• 3 Dll4 Signalling in Cancer Neoangiogenesis (p.412)
• 4 Targeting Dll4 Signalling in Cancer (p.414)
• 5 Exploring Dll4 Gain-of-Function as an Approach to Cancer Therapy (p.417)
• 6 A Potential Role for Dll4 Signalling in Metastasis Development (p.418)
• 7 Targeting Notch Signalling to Improve Physiological Angiogenesis (p.419)
• 8 Conclusion (p.420)
• References (p.420)
• 1 Introduction (p.424)
• 2 Clinical Presentation (p.426)
• 3 Treatment Options (p.427)
• 4 New Insights on the New Biomarkers: HER2 E CXCR4/SDF-1 Axis (p.428)
• 5 Understanding the Role of miRNAs on FMC (p.431)
• 6 Exploring Efficacy of TKIs, HDACIs and MTIs in FMC (p.432)
• References (p.434)
• 1 Antibodies (Igs) as Immunotherapeutic Tools (p.441)
• 2 Selection and Screening of Recombinant Antibodies (p.444)
• 3 The New Generation of Recombinant Antibodies of Rabbit Origin (p.447)
• 4 Potential Applications of Rabbit Derived sdAbs (p.448)
• 5 Development of Specific Recombinant sdAbs Against gp120 HIV Glycoprotein (p.448)
• 6 Development of Recombinant Antibodies and Small Molecule Compounds for Diagnosis and Treatment of Naturally Occurring Canine Lymphoma (p.451)
• 7 Development of Recombinant sdAbs for Brain Targeting and Drug Delivery Across the Blood-Brain Barrier (p.455)
• 8 Conclusions (p.458)
• References (p.459)
• 1 Introduction (p.465)
• 2 Companion Animals in Clinical Research (p.466)
• 3 Canine Atopic Models (p.467)
• 4 Canine Atopic Dermatitis (p.470)
• 5 Canine Allergic Conjunctivitis (p.472)
• 6 Oral Squamous Cell Carcinoma Spontaneous Models (p.475)
• References (p.477)
• 1 Introduction (p.480)
• 2 In Vitro Ocular Membrane Permeation to EPO Protein (p.481)
• 3 Subconjunctival Administration in Physiologic Conditions (p.482)
• 4 Subconjunctival Administration in Glaucomatous Conditions (p.484)
• 5 Assessment of Functional and Structural Benefits of Subconjunctival EPO (p.485)
• 6 Limitations of the Study (p.485)
• 7 Future Directions (p.487)
• References (p.488)
• 1 Upper Airway Tract (p.490)
• 2 Lower Airway Tract (p.497)
• 3 Diagnostic (p.501)
• References (p.505)
• 1 Introduction (p.515)
• 2 Uteropathogenic E. Coli (p.516)
• 3 Host Defenses Against E. Coli Colonization of the Uterus (p.520)
• 4 Neutrophil Extracellular Traps (NETs) (p.525)
• 5 UtPEC and UPEC as a Zoonotic Risk (p.525)
• 6 Conclusions (p.526)
• References (p.526)
• 1 Introduction (p.533)
• 2 Endocrine Environment in the Endometrium (p.534)
• 3 Cytokines and Prostaglandins in Healthy Mare Endometrium (p.535)
• 4 Cytokines and Prostaglandins in the Unhealthy Endometrium (p.536)
• 5 Fibrosis in Mare Endometrium and Oviduct (p.537)
• References (p.541)
• 1 Definition and Aetiology (p.546)
• 2 Pathophysiology (p.547)
• 3 Clinical Signs (p.548)
• 4 Clinical Pathology (p.550)
• 5 Prognosis (p.551)
• 6 Treatment (p.553)
• 7 Prevention (p.556)
• 8 Conclusions (p.559)
• References (p.559)
• ... and 37 more chapters

🔗 Download Link: